PEPTIDE CORPUS

Miscellaneous & Research; Cognitive & Neuroprotection

Neurotensin

Space-filling model of Neurotensin

Last updated

Evidence on file1 human observational study · 1 animal study · 1 citation not yet graded
Strongest sourceNCT04179331: Neurotensin Infusions in Healthy Individuals - Effects on Appetite, Food Intake, Hormone Secreti… (human observational study)

Dosing on file unverified

2.5, 5.0, 7.5 pmol/kg/min sequential IV infusion (each 1h); 2.3 pmol/kg/min for 30 min; 2.5-7.5 pmol/kg/min IV infusion (1h each dose, sequential)

Carried from a source that labels it unverified, and reproduced with that label attached. A record of what is reported, not a recommendation. No citation on this page establishes it.

Literature on file 3

Not graded

1 citation whose study design could not be read from the title. Left ungraded rather than guessed at.

Identity

PubChem CID 25077406 computed 3D conformer Space-filling 3D model of Neurotensin, carbon grey, nitrogen blue, oxygen red
Built from the SMILES on this record — the atoms, bonds and stereochemistry are exact. The shape is one computed low-energy pose, not a measured structure: a flexible peptide in solution has no single conformation. The skeletal formula below claims connectivity and nothing more, which is what we actually know.
Skeletal formulathe canonical depiction
2D chemical structure of Neurotensin

Drawn by PubChem from CID 25077406, the identifier on this record.

Molecular weight
1672.9
Molecular formula
C78H121N21O20
CAS number
39379-15-2
PubChem CID
25077406
UniProt
P30990 (precursor)
InChI key
PCJGZPGTCUMMOT-ISULXFBGSA-N
SMILES
CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]3CCCN3C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]5CCC(=O)N5
InChI
InChI=1S/C78H121N21O20/c1-7-43(6)63(73(115)96-57(76(118)119)37-42(4)5)97-70(112)55(39-45-21-25-47(101)26-22-45)95-72(114)59-18-13-35-99(59)75(117)52(16-11-33-86-78(83)84)90-64(106)48(15-10-32-85-77(81)82)89-71(113)58-17-12-34-98(58)74(116)51(14-8-9-31-79)91-69(111)56(40-60(80)102)94-66(108)50(28-30-62(104)105)88-68(110)54(38-44-19-23-46(100)24-20-44)93-67(109)53(36-41(2)3)92-65(107)49-27-29-61(103)87-49/h19-26,41-43,48-59,63,100-101H,7-18,27-40,79H2,1-6H3,(H2,80,102)(H,87,103)(H,88,110)(H,89,113)(H,90,106)(H,91,111)(H,92,107)(H,93,109)(H,94,108)(H,95,114)(H,96,115)(H,97,112)(H,104,105)(H,118,119)(H4,81,82,85)(H4,83,84,86)/t43-,48-,49-,50-,51-,52-,53-,54-,55-,56-,57-,58-,59-,63-/m0/s1

Caveat on these identifiers

Source files disagreed on evidence tier for this peptide.

Notes unverified prose

NCT04179331; 2.3 pmol/kg/min in healthy subjects; NCT04179331: 2.5, 5.0, 7.5 pmol/kg/min sequential IV infusions; NCT04179331 (2.5, 5.0, 7.5 pmol/kg/min IV); NCT04179331 (human IV infusions)

Not on file 1

1 of the 8 fields we track hold nothing on this record, and each says why. A blank field is a bug; a named absence is a finding.

Each field links to every other record missing the same thing. The full ledger holds 521 gaps across 136 records.

Share this record

Share card for Neurotensin: structure, evidence rung and sources on file
www.peptidecorpus.com/peptides/neurotensin